Related references
Note: Only part of the references are listed.Impaired glycemia and Alzheimer's disease
Jill K. Morris et al.
NEUROBIOLOGY OF AGING (2014)
Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo
Su-Su Tang et al.
NEUROBIOLOGY OF AGING (2014)
Association of type 2 diabetes with brain atrophy and cognitive impairment
Rosebud O. Roberts et al.
NEUROLOGY (2014)
Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice
Jin'e Lai et al.
NEUROPHARMACOLOGY (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Pretreatment with antiasthmatic drug ibudilast ameliorates Aβ1-42-induced memory impairment and neurotoxicity in mice
Hao Wang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation
Li-ping Liu et al.
ACTA PHARMACOLOGICA SINICA (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: NUCLEAR HORMONE RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice
Li Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Leukotriene D4 induces cognitive impairment through enhancement of CysLT1R-mediated amyloid-β generation in mice
Su-Su Tang et al.
NEUROPHARMACOLOGY (2013)
Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance
Itender Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
PPAR? Agonist Pioglitazone Reverses Memory Impairment and Biochemical Changes in a Mouse Model of Type 2 Diabetes Mellitus
Li-Ying Jiang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Sink Hypothesis and Therapeutic Strategies for Attenuating Aβ Levels
Yan Zhang et al.
NEUROSCIENTIST (2011)
Western diet consumption and cognitive impairment: Links to hippocampal dysfunction and obesity
Scott E. Kanoski et al.
PHYSIOLOGY & BEHAVIOR (2011)
Cognitive and Emotional Alterations Are Related to Hippocampal Inflammation in a Mouse Model of Metabolic Syndrome
Anne-Laure Dinel et al.
PLOS ONE (2011)
The many facets of PPARγ: novel insights for the skeleton
Masanobu Kawai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Transporters in the Brain Endothelial Barrier
M. Ueno et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Does Peroxisome Proliferator-activated Receptor-γ (PPARγ) Protect from Hypertension Directly through Effects in the Vasculature?
Pimonrat Ketsawatsomkron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging
Robert D. Bell et al.
NEURON (2010)
Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis
Yvonne S. Eisele et al.
SCIENCE (2010)
Metabolic links between diabetes and Alzheimer's disease
Pamela A. Maher et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities
Wen Huang et al.
FASEB JOURNAL (2009)
Risk of Incident Alzheimer's Disease in Diabetic Patients: A Systematic Review of Prospective Trials
Daniel Kopf et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Downregulation of LPR1 at the blood-brain barrier in streptozotocin-induced diabetic mice
Hao Hong et al.
NEUROPHARMACOLOGY (2009)
Upregulation of RAGE at the Blood-Brain Barrier in Streptozotocin-Induced Diabetic Mice
Li Ping Liu et al.
SYNAPSE (2009)
Diabetes, cognitive function, and the blood-brain barrier
J. D. Huber
CURRENT PHARMACEUTICAL DESIGN (2008)
Cognitive dysfunction and diabetes mellitus
Christopher T. Kodl et al.
ENDOCRINE REVIEWS (2008)
Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling
Andreas M. Beyer et al.
HYPERTENSION (2008)
Activation of peroxisome proliferator-activated receptor γ (PPARγ) suppresses rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes
Servio H. Ramirez et al.
JOURNAL OF IMMUNOLOGY (2008)
Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2
Troy T. Rohn et al.
JOURNAL OF NEUROSCIENCE (2008)
Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons
Alexis M. Stranahan et al.
NATURE NEUROSCIENCE (2008)
Increased amyloid β-peptide (1-40) level in brain of streptozotocin-induced diabetic rats
Y. Liu et al.
NEUROSCIENCE (2008)
Functional induction of P-glycoprotein in the blood-brain barrier of streptozotocin-induced diabetic rats:: evidence for the involvement of nuclear factor-κb, a nitrosative stress-sensitive transcription factor, in the regulation
Han-Joo Maeng et al.
DRUG METABOLISM AND DISPOSITION (2007)
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease
B. D. Zipser et al.
NEUROBIOLOGY OF AGING (2007)
Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats
Haiyan Liu et al.
BRAIN RESEARCH (2006)
Diabetes, leukoencephalopathy and rage
Cory Toth et al.
NEUROBIOLOGY OF DISEASE (2006)
Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides
A Awasthi et al.
EXPERIMENTAL NEUROLOGY (2005)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
JR Cirrito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Gene expression profiling of potential PPARγ target genes in mouse aorta
HL Keen et al.
PHYSIOLOGICAL GENOMICS (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor γ
A Gauthier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
D Stern et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier
M Fiala et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
